Answers are grounded in this paper and cite their sources.
In vitro study demonstrates that cultured CD71+ erythroid cells boost T cell proliferation and suppress inflammatory cytokines, indicating immunomodulatory effects of lab-grown blood.
Objective The study aimed to determine the impact of Red Blood Cells (RBCs) generated from peripheral blood mononuclear cells (PBMCs) on T cell proliferation and host response following whole blood stimulation. Background Culturing RBCs is a potential solution for donor shortage. The impact of immature cultured RBCs which express CD71 + on host immune response is not known. Methods/Materials PBMCs were seeded in an erythroid expansion medium. CD71 + cells were isolated at days 14 and 21 of culture and incubated with either purified T cells or with LPS‐stimulated whole blood. Controls were incubated with medium. Results At day 9, the percentage of cells that expressed CD45 and CD71 reached to the highest level (32.9%, IQR; 26.2–39.05) while the percentage of cells that expressed CD71 and CD235a reached to the highest level on day 17 (70.2%, IQR; 66.1–72.8). Incubation of T cells with days 14 CD71 + cells and day 21 CD71 + cells increased T cell proliferation. In a whole blood stimulation assay, day 21 CD71 + cells, but not day 14 CD71 + cells, inhibited the production of IL‐6 and TNFα. Conclusion Cultured erythroid cells can modulate the immune response by promoting T cell proliferation and inhibiting cytokine secretions following whole blood stimulation.
No takes yet. Share an insight, caveat, or question.
Alshalani et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: